Non Squamous NSCLC Patients With Anlotinib Combined With Pemetrexed and Cisplatin
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Anlotinib
Related studies linked through entity extraction aliases.
Anlotinib for Advanced and Refractory Natural Killer /T-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of the Combination of Anlotinib With Gefitinib
- Status
- UNKNOWN
- Phase
- NA
A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas
- Status
- UNKNOWN
- Phase
- PHASE2
Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel
- Status
- UNKNOWN
- Phase
- NA
Study of Anlotinib in Patients With Primary Malignant Bone Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3
- Status
- UNKNOWN
- Phase
- PHASE2
Anlotinib and Irinotecan for Ewing Sarcoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202)
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Anlotinib in Patients With Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics
- Status
- UNKNOWN
- Phase
- PHASE1
Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032)
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203)
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0303）
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs Therapy
- Status
- UNKNOWN
- Phase
- PHASE2